Management of Comorbidities in Difficult and Severe Asthma
Overview
Affiliations
Difficult-to-treat and severe asthma are challenging clinical entities. In the face of suboptimal asthma control, the temptation for clinicians is to reflexively escalate asthma-directed therapy, including increasing exposure to corticosteroids and commencement of costly but potent biologic therapies. However, asthma control is objectively and subjectively assessed based on measurable parameters (such as exacerbations or variability in pulmonary physiology), symptoms and patient histories. Crucially, these features can be confounded by common untreated comorbidities, affecting clinicians' assessment of asthma treatment efficacy.
DAiuto V, Mormile I, Granata F, Romano A, Della Casa F, Mignogna G Int J Mol Sci. 2025; 26(4).
PMID: 40004192 PMC: 11855446. DOI: 10.3390/ijms26041729.
Maintenance oral steroids are not required in severe asthma.
Graham E, Eames C, Soe W, Fox L, Whitfield C, Kerley S ERJ Open Res. 2024; 10(6).
PMID: 39687394 PMC: 11647928. DOI: 10.1183/23120541.00568-2024.
The role of radiological imaging in the management of severe and difficult-to-treat asthma.
Aigbirior J, Almaghrabi A, Lafi M, Mansur A Breathe (Sheff). 2024; 20(2):240033.
PMID: 39015661 PMC: 11249838. DOI: 10.1183/20734735.0033-2024.